IN2014DN09522A - - Google Patents

Info

Publication number
IN2014DN09522A
IN2014DN09522A IN9522DEN2014A IN2014DN09522A IN 2014DN09522 A IN2014DN09522 A IN 2014DN09522A IN 9522DEN2014 A IN9522DEN2014 A IN 9522DEN2014A IN 2014DN09522 A IN2014DN09522 A IN 2014DN09522A
Authority
IN
India
Application number
Inventor
Nicoletta Maxia
Original Assignee
Nicoletta Maxia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46321277&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN09522(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nicoletta Maxia filed Critical Nicoletta Maxia
Publication of IN2014DN09522A publication Critical patent/IN2014DN09522A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • A61B17/435—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for embryo or ova transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B2017/4216—Operations on uterus, e.g. endometrium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/80—Neurotransmitters; Neurohormones
    • C12N2501/825—Serotonine (5-HT); Melatonine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN9522DEN2014 2012-05-28 2014-11-12 IN2014DN09522A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000913A ITMI20120913A1 (en) 2012-05-28 2012-05-28 USE OF N-ACETHYL-5-METHOXY-RIPTAMIN OR ITS ANALOGUES TO ENCOURAGE THE EMBRYO PLANT MECHANISM, AND RELATIVE COMPOSITIONS AND MEANS OF CULTURE
PCT/EP2013/060872 WO2013178587A1 (en) 2012-05-28 2013-05-27 Use of n-acetyl-5-methoxytryptamine or analogues thereof, for promoting the mechanism of implantation of the embryo and related compositions and culture media

Publications (1)

Publication Number Publication Date
IN2014DN09522A true IN2014DN09522A (en) 2015-07-17

Family

ID=46321277

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9522DEN2014 IN2014DN09522A (en) 2012-05-28 2014-11-12

Country Status (18)

Country Link
US (2) US10034856B2 (en)
EP (1) EP2854790B1 (en)
JP (1) JP6401152B2 (en)
KR (2) KR102095411B1 (en)
CN (2) CN104334167A (en)
AU (1) AU2013269728B2 (en)
BR (1) BR112014029116A2 (en)
CA (1) CA2869534A1 (en)
ES (1) ES2699807T3 (en)
HK (1) HK1201725A1 (en)
IL (1) IL235373B (en)
IN (1) IN2014DN09522A (en)
IT (1) ITMI20120913A1 (en)
MX (1) MX363007B (en)
RU (1) RU2657601C2 (en)
SG (1) SG11201406284WA (en)
WO (1) WO2013178587A1 (en)
ZA (1) ZA201407368B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (en) 2011-11-23 2021-09-30 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (en) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. NATURAL COMBINED HORMONE SUBSTITUTION COMPOSITIONS AND THERAPIES
EP3258910A1 (en) * 2015-02-17 2017-12-27 Ares Trading S.A. Topical liquid composition comprising melatonin
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CN106474133B (en) * 2016-09-21 2019-07-26 北京市农林科学院 A preparation for improving the conception rate of dairy cows and its application
EP3999846A4 (en) 2019-07-25 2023-08-09 Overture Life, Inc Identification of viable human embryos
CN113215087A (en) * 2021-05-31 2021-08-06 广西壮族自治区畜牧研究所 Method for improving in-vitro maturation development rate of porcine oocytes by adopting agomelatine
JP2025524026A (en) * 2022-07-22 2025-07-25 セルマティクス インク． Compositions and methods for peripheral targeting of melatonin receptor agonists - Patents.com

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5749845A (en) 1995-01-25 1998-05-12 Iotek, Inc. Delivering an agent to an organ
SI0948358T2 (en) * 1996-12-24 2012-03-30 Biogen Idec Inc Stable liquid interferon formulations
KR100303662B1 (en) * 1998-06-10 2001-12-12 황기준 Method for preparing N-acetyl-5-methoxytrytamine
CN101208422A (en) * 2005-02-23 2008-06-25 威廉·A·库克澳大利亚股份有限公司 Culture device
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2008036979A2 (en) * 2006-09-22 2008-03-27 Guilford F Timothy Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non-histamine related inflammatory skin changes
RU2459624C2 (en) 2007-04-12 2012-08-27 Риджентс Оф Дзе Юниверсити Оф Миннесота Protective compositions for ischemia/reperfusion and methods for using them
CN102250832B (en) * 2011-05-30 2012-08-15 中国农业大学 Culture liquid for promoting ectogenesis of frozen embryo after thawing

Also Published As

Publication number Publication date
RU2014150657A (en) 2016-07-20
US10583118B2 (en) 2020-03-10
JP2015525210A (en) 2015-09-03
US10034856B2 (en) 2018-07-31
AU2013269728A1 (en) 2014-10-23
CN111035637A (en) 2020-04-21
CA2869534A1 (en) 2013-12-05
KR20200036039A (en) 2020-04-06
CN104334167A (en) 2015-02-04
MX363007B (en) 2019-03-04
KR20150022886A (en) 2015-03-04
EP2854790A1 (en) 2015-04-08
JP6401152B2 (en) 2018-10-03
WO2013178587A1 (en) 2013-12-05
RU2657601C2 (en) 2018-06-14
HK1201725A1 (en) 2015-09-11
MX2014014123A (en) 2015-05-12
SG11201406284WA (en) 2014-11-27
KR102095411B1 (en) 2020-04-01
ES2699807T3 (en) 2019-02-12
AU2013269728B2 (en) 2017-10-05
ITMI20120913A1 (en) 2013-11-29
US20180303798A1 (en) 2018-10-25
BR112014029116A2 (en) 2017-06-27
ZA201407368B (en) 2016-03-30
US20150150847A1 (en) 2015-06-04
IL235373B (en) 2018-02-28
EP2854790B1 (en) 2018-08-29

Similar Documents

Publication Publication Date Title
BR112014017684A2 (en)
BR112014017625A2 (en)
BR112014017659A2 (en)
BR112014017592A2 (en)
BR112014017607A2 (en)
BR112014017646A2 (en)
BR112014017638A2 (en)
AR092201A1 (en)
BR112013027865A2 (en)
BR112014017644A2 (en)
BR112014017634A2 (en)
BR112014017588A2 (en)
BR112014017647A2 (en)
BR112014013184A8 (en)
BR112014017618A2 (en)
BR112014017627A2 (en)
BR112014017623A2 (en)
BR112014017652A2 (en)
BR112014017630A2 (en)
BR112014017621A2 (en)
BR112014017631A2 (en)
BR112014017641A2 (en)
BR112014017671A2 (en)
BR112014017589A2 (en)
BR112014017600A2 (en)